Registered nurse Cathie Zimmerman takes a blood sample from Ginger Bridges who received her first shot in the AstraZeneca COVID-19 vaccine trial on Dec. 10, 2020, at Clinical Trials of South Carolina in North Charleston. After receiving the vaccine or a placebo, she will return for a second shot 29 days later. Andrew J. Whitaker/Staff By Andrew J. Whitaker awhitaker@postandcourier.com
This article previously published on Dec. 15 as part of our South Carolina COVID-19 vaccine rollout coverage. Weâre promoting it again after Gov. Henry McMaster added 2.7 million people to South Carolinaâs vaccine eligibility list.
Inside a little brick building in North Charleston, where research of global importance was underway, Ginger Bridges tugged her neckline down a few inches to expose her left shoulder.